The OneVentures healthcare team has a strong history of biomedical entrepreneurship, with experience commercialising biomedical innovation across the United States, Europe, United Kingdom and Australia.
OneVentures’ investing strategy focuses on investing to milestones – to ensure we are only partnering with those companies that are performing and achieving key validation steps. We look towards proof of clinical efficacy and safety, backed by quality science with a clear regulatory and reimbursement path.
We take a hands on approach with our investments, and believe in the quality of people and relationships to deliver long term success. With a history of achievement in transforming ideas, technologies and products into successful businesses, our collaborative approach looks to deliver successful outcomes for all our stakeholders.
Developing a novel approach to allergen immunotherapy - providing long lasting peace of mind to food allergy sufferers